Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11728
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZajac, Jeffrey Den
dc.contributor.authorFui, Mark Ng Tangen
dc.date.accessioned2015-05-16T01:21:14Z
dc.date.available2015-05-16T01:21:14Z
dc.date.issued2012en
dc.identifier.citationAdvances in Experimental Medicine and Biology; 769(): 153-68en
dc.identifier.govdoc23560310en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11728en
dc.description.abstractKennedy's disease (KD) or spinobulbar muscular atrophy is a hereditary X-linked, progressive neurodegenerative condition caused by an expansion of the CAG triplet repeat in the first exon of the androgen receptor gene. The phenotype in its full form is only expressed in males and presents as weakness and wasting of the upper and lower limbs and bulbar muscles associated with absent reflexes. Sensory disturbances are present. Various endocrine abnormalities including decreased fertility and gynecomastia are common and amongst the first features of KD. Animal models of KD have demonstrated improvement on withdrawal of testosterone, indicating that this agonist of the androgen receptor is required for the toxic effect. Potential therapies based on testosterone withdrawal in humans have shown some promise, but efficacy remains to be proven. Potential clinical factors, pathogenesis and future approaches to therapy are reviewed in this chapter.en
dc.language.isoenen
dc.subject.other46, XX Disorders of Sex Development.physiopathologyen
dc.subject.otherAromatase.deficiencyen
dc.subject.otherBulbo-Spinal Atrophy, X-Linked.drug therapy.genetics.metabolism.physiopathologyen
dc.subject.otherDrugs, Investigational.pharmacology.therapeutic useen
dc.subject.otherExonsen
dc.subject.otherGynecomastia.physiopathologyen
dc.subject.otherHumansen
dc.subject.otherInfertility, Male.physiopathologyen
dc.subject.otherMaleen
dc.subject.otherMetabolism, Inborn Errors.physiopathologyen
dc.subject.otherPeptides.geneticsen
dc.subject.otherReceptors, Androgen.genetics.metabolismen
dc.subject.otherSex Factorsen
dc.subject.otherTestosterone.antagonists & inhibitors.metabolismen
dc.subject.otherTrinucleotide Repeat Expansionen
dc.titleKennedy's disease: clinical significance of tandem repeats in the androgen receptor.en
dc.typeJournal Articleen
dc.identifier.journaltitleAdvances in Experimental Medicine and Biologyen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne at Austin Health, Heidelberg, Victoria, Australiaen
dc.description.pages153-68en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/23560310en
dc.type.austinJournal Articleen
local.name.researcherZajac, Jeffrey D
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

68
checked on Mar 10, 2025

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.